Frequency of infusion-related reactions with CPX-351 treatment in an observational study in adults with newly diagnosed therapy-related AML or AML with myelodysplasia-related changes (AML-MRC)

Meagan A. Jacobya Washington University School of Medicine, St. Louis, MO, USACorrespondence[email protected]
View further author information

Ashkan Emadic University of Maryland Greenebaum Comprehensive Cancer Center, Baltimore, MD, USAView further author information

Nakhle S. Sabad Tulane University School of Medicine, New Orleans, LA, USA

Bayard L. Powelle Wake Forest Baptist Comprehensive Cancer Center, Winston-Salem, NC, USAView further author information

Karen Seiterf New York Medical College, Valhalla, NY, USAView further author information

Heather J. Maleh University of Kansas Medical Center, Kansas City, KS, USAView further author information

Citations (2)

Keep up to date with the latest research on this topic with citation updates for this article.